Aisling Capital Management LP - EIDOS THERAPEUTICS INC ownership

EIDOS THERAPEUTICS INC's ticker is EIDX and the CUSIP is 28249H104. A total of 123 filers reported holding EIDOS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.50 and the average weighting 0.6%.

Quarter-by-quarter ownership
Aisling Capital Management LP ownership history of EIDOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$147,847,000
+160.4%
1,123,6300.0%25.39%
+40.0%
Q3 2020$56,777,000
+6.0%
1,123,6300.0%18.14%
-11.3%
Q2 2020$53,563,000
-2.7%
1,123,6300.0%20.44%
-14.8%
Q1 2020$55,047,000
-14.6%
1,123,6300.0%23.98%
-2.9%
Q4 2019$64,485,000
+59.5%
1,123,6300.0%24.71%
+17.3%
Q3 2019$40,417,000
+15.7%
1,123,6300.0%21.07%
+41.3%
Q2 2019$34,922,000
+32.5%
1,123,6300.0%14.92%
-25.7%
Q1 2019$26,349,000
+70.4%
1,123,6300.0%20.07%
+23.2%
Q4 2018$15,461,0001,123,63016.29%
Other shareholders
EIDOS THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,123,630$56,777,00018.14%
Board of Trustees of The Leland Stanford Junior University 265,670$13,425,0005.17%
Opaleye Management Inc. 315,550$15,945,0003.12%
RA Capital Management 2,163,271$109,310,0002.00%
Cormorant Asset Management, LP 993,185$50,186,0001.93%
Parkman Healthcare Partners LLC 41,091$2,076,0000.55%
Perceptive Advisors 686,922$34,710,0000.51%
Redmile Group, LLC 466,205$23,557,0000.43%
Eventide Asset Management 317,417$16,039,0000.31%
Ikarian Capital, LLC 63,011$3,184,0000.23%
View complete list of EIDOS THERAPEUTICS INC shareholders